CUSIP: 55028X109
What is CUSIP 55028X109?
CUSIP 55028X109 identifies LUMO - LUMOS PHARMA INC - Common Stock in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Open recent reporting periods for CUSIP 55028X109:
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| WELLS FARGO & COMPANY/MN | 0.8% | $251,476 | 64,981 | Wells Fargo & Company | 30 Sep 2024 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q1 | 0 | $0 | -$387 | 0 | |
| 2024 Q4 | 0 | $0 | -$8,080,749 | 0 | |
| 2024 Q3 | 2,088,150 | $8,080,749 | +$437,841 | $3.87 | 28 |
| 2024 Q2 | 2,077,959 | $4,820,513 | -$285,684 | $2.32 | 35 |
| 2024 Q1 | 2,176,429 | $6,137,561 | -$538,428 | $2.82 | 35 |
| 2023 Q4 | 2,367,345 | $7,518,364 | -$233,151 | $3.18 | 36 |
| 2023 Q3 | 2,440,661 | $8,054,168 | +$72,858 | $3.30 | 33 |
| 2023 Q2 | 2,393,809 | $7,897,148 | +$530,492 | $3.30 | 34 |
| 2023 Q1 | 2,232,913 | $7,403,267 | -$643,185 | $3.31 | 34 |
| 2022 Q4 | 2,360,021 | $8,575,404 | -$534,037 | $3.61 | 35 |
| 2022 Q3 | 2,511,198 | $22,225,824 | +$1,762,681 | $8.85 | 29 |
| 2022 Q2 | 2,324,202 | $17,893,638 | -$854,512 | $7.70 | 32 |
| 2022 Q1 | 2,481,066 | $23,335,869 | -$1,872,873 | $9.40 | 31 |
| 2021 Q4 | 2,701,081 | $18,721,286 | -$1,209,298 | $6.93 | 30 |
| 2021 Q3 | 2,865,997 | $27,253,391 | -$3,434,888 | $9.51 | 30 |
| 2021 Q2 | 3,202,560 | $32,064,510 | -$1,155,624 | $10.00 | 33 |
| 2021 Q1 | 3,314,846 | $38,788,642 | -$8,023,294 | $11.70 | 33 |
| 2020 Q4 | 3,769,462 | $134,566,447 | +$4,555,911 | $35.71 | 43 |
| 2020 Q3 | 3,634,580 | $50,231,000 | +$825,027 | $13.82 | 33 |
| 2020 Q2 | 3,561,990 | $58,740,000 | +$5,044,218 | $16.49 | 36 |
| 2020 Q1 | 3,277,359 | $27,859,000 | +$27,733,000 | $8.50 | 39 |